| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.07 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |